349 related articles for article (PubMed ID: 33929911)
1. Nanobody Conjugates for Targeted Cancer Therapy and Imaging.
Kang W; Ding C; Zheng D; Ma X; Yi L; Tong X; Wu C; Xue C; Yu Y; Zhou Q
Technol Cancer Res Treat; 2021; 20():15330338211010117. PubMed ID: 33929911
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumors with nanobodies for cancer imaging and therapy.
Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
[TBL] [Abstract][Full Text] [Related]
3. Nanobody-A versatile tool for cancer diagnosis and therapeutics.
Liu M; Li L; Jin D; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1697. PubMed ID: 33470555
[TBL] [Abstract][Full Text] [Related]
4. Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.
Sun S; Ding Z; Yang X; Zhao X; Zhao M; Gao L; Chen Q; Xie S; Liu A; Yin S; Xu Z; Lu X
Int J Nanomedicine; 2021; 16():2337-2356. PubMed ID: 33790553
[TBL] [Abstract][Full Text] [Related]
5. Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging.
Hebbrecht T; Liu J; Zwaenepoel O; Boddin G; Van Leene C; Decoene K; Madder A; Braeckmans K; Gettemans J
N Biotechnol; 2020 Nov; 59():33-43. PubMed ID: 32659511
[TBL] [Abstract][Full Text] [Related]
6. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
Front Immunol; 2021; 12():838082. PubMed ID: 35116045
[TBL] [Abstract][Full Text] [Related]
7. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
[TBL] [Abstract][Full Text] [Related]
8. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics.
Naidoo DB; Chuturgoon AA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575943
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
Li B; Qin X; Mi LZ
Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
[TBL] [Abstract][Full Text] [Related]
11. Conjugation of IRDye Photosensitizers or Fluorophores to Nanobodies.
Mashayekhi V; Oliveira S
Methods Mol Biol; 2022; 2451():495-503. PubMed ID: 35505027
[TBL] [Abstract][Full Text] [Related]
12. Nanobodies and Cancer: Current Status and New Perspectives.
Allegra A; Innao V; Gerace D; Vaddinelli D; Allegra AG; Musolino C
Cancer Invest; 2018 Apr; 36(4):221-237. PubMed ID: 29658806
[TBL] [Abstract][Full Text] [Related]
13. Immunotoxins and nanobody-based immunotoxins: review and update.
Khirehgesh MR; Sharifi J; Safari F; Akbari B
J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies as molecular imaging probes.
Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
[TBL] [Abstract][Full Text] [Related]
15. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
16. Nanobodies and their potential applications.
Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
[TBL] [Abstract][Full Text] [Related]
17. Nanobodies in cancer.
Verhaar ER; Woodham AW; Ploegh HL
Semin Immunol; 2021 Feb; 52():101425. PubMed ID: 33272897
[TBL] [Abstract][Full Text] [Related]
18. Nanobodies as Versatile Tool for Multiscale Imaging Modalities.
Erreni M; Schorn T; D'Autilia F; Doni A
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33353213
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
20. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]